Nearly 40% of Cancer Clinical Trials Disrupted By COVID-19 Are Restarting; Guidance for Patients

Published Aug 17, 2020

Nearly 40% of Cancer Clinical Trials Disrupted By COVID-19 Are Restarting; Guidance for Patients

Patients and doctors are encouraged that clinical trials have started up again. A leading expert talks to SurvivorNet about why you shouldn't be afraid to consider a clinical trial during the outbreak.

NOW
PLAYING
With Wildfires Raging Across the West Coast a Leading Expert Tells Us How Cancer Patients Can Stay Safe
NOW
PLAYING
Top Facebook Executive, Lady Nicola Mendelsohn, 49, Says COVID-19 Has Stopped Her Treatments For Rare Cancer; She Doesn't Know When They'll Resume
NOW
PLAYING
People With Blood Cancer Are More Vulnerable to COVID-19
NOW
PLAYING
Should Cancer Patients Fly During a Pandemic?
NOW
PLAYING
COVID-19 and Ovarian Cancer Treatment
NOW
PLAYING
Ovarian Cancer Decision Making
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.